Axcella Therapeutics (Nasdaq: AXLA) continues to gain traction the following week after their astonishing announcement, gaining over 40% at peak trading hours on August 7th, 2023....
Virios Therapeutics, Inc. (NASDAQ: VIRI), a biotechnology company focused on advancing groundbreaking antiviral treatments for chronic conditions like fibromyalgia and Long-COVID, has experienced significant momentum over...
On August 15th, 2023, an impressive 104 million shares were traded as Delcath Systems, Inc. (NASDAQ: DCTH) unveiled a revolutionary update about their HEPZATO KIT. Surging...